Please login or register first to view this content.
News
NEWS
Latest News
Valve-In-Valve TAVR vs SAVR: Short- and Long-Term Outcomes
Epicardial Spasms May Increase the Risk for Myocardial Infarction
Guideline-Concordant Gout Therapy Associated With Improved Arterial Function
Venous Thromboembolism Events With COVID-19 in an Intensive Care Unit
ACC Guidance for CV Specialists for the Initiation, Management of Glucose-Lowering Therapy in Type 2 Diabetes
COVID-19 With Concurrent STEMI May Be Associated With High Thrombus Burden
CTEPH Severity Assessed by Dual Energy CT Parameters and Hemodynamics
![The most frequent cardiovascular manifestations of AS are aortic insufficiency and conduction disorders.[2] Up to 20% of patients with AS have conduction disorders, of which atrioventricular block is the most common.[5,6] Compared with the general population, patients with AS have a 30% to 50% increase in the risk of acute coronary syndromes, deep venous thromboembolism, pulmonary embolism, or stroke.[8] They also have a 25% to 60% greater risk of ischemic heart disease, congestive heart failure, and valvular heart disease.[9] Heart failure may occur secondary to mitral insufficiency.[2] Aortic dissection, which is a rare but frequently fatal complication of aortic insufficiency, has also been observed in patients with AS.[2] Other potential cardiovascular complications include left ventricular diastolic dysfunction, pericarditis, myocardial disease, peripheral vascular disease, and hypertension.[2,3,5]](https://3fvcugvijkt9bj7w3wf2t712-wpengine.netdna-ssl.com/wp-content/uploads/sites/17/2019/01/thinkstockphotos474641458101_1032729.jpg)
Prasugrel Dose Adapted to Age, Weight Found Efficacious for ACS
Pulmonary Hypertension in COVID-19 Associated With Greater Disease Severity
Drug News from MPR
BP Dipping May Be a Marker of CV Function in Pediatric-Onset SLE
FDA Issues Emergency Use Authorization for Point-of-Care COVID-19 Tests
Ozempic Approved to Reduce Risk of Major Adverse Cardiovascular Events
Provider Gaps Identified in Cardiopulmonary Care
Rilonacept Gets Breakthrough Therapy Status for Recurrent Pericarditis
Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth
Oral Suspension Formulation of Amlodipine Now Available
How I Treat My Patients With Sacubitril/Valsartan for Heart Failure With Reduced Ejection Fraction
Rivaroxaban Appears Safe, Effective for Pediatric Acute VTE
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
-
Loading...
-
Loading...
Want to read more?
Next post in Heart Failure
